• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Immunome, Inc. - Common Stock (NQ:IMNM)

    10.15 -1.04 (-9.33%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,242,845
    Open 10.89
    Bid (Size) 10.15 (1)
    Ask (Size) 11.00 (7)
    Prev. Close 11.20
    Today's Range 10.00 - 11.02
    52wk Range 5.150 - 15.20
    Shares Outstanding 87,012,328
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Where Immunome Stands With Analysts
     
    Via Benzinga
    This Crocs Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
     
    Via Benzinga

    Performance

    YTD
    -3.6%
    -3.6%
    1 Month
    +2.4%
    +2.4%
    3 Month
    +17.0%
    +17.0%
    6 Month
    +43.2%
    +43.2%
    1 Year
    -30.5%
    -30.5%

    More News

    Read More
    This GATX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
    Via Benzinga
    Infinimmune Announces Research Collaboration with Immunome
    From Infinimmune
    Via Business Wire
    Where Immunome Stands With Analysts
    Via Benzinga
    Immunome Stock Rises After Craig-Hellum Initiates Coverage With $26 Price Target: Here’s Why The Analyst Sees An ‘Attractive Entry Point’
    Via Stocktwits
    Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Immunome, Inc.
    Via Business Wire
    Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference
    From Immunome, Inc.
    Via Business Wire
    This Netgear Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
    Via Benzinga
    Immunome (IMNM) Q2 Revenue Surges 382%
    Via The Motley Fool
    Immunome Reports Second Quarter 2025 Financial Results and Provides Business Update
    From Immunome, Inc.
    Via Business Wire
    Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Immunome, Inc.
    Via Business Wire
    Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Immunome, Inc.
    Via Business Wire
    These stocks are moving in today's after hours session
    Via Chartmill
    Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Immunome, Inc.
    Via Business Wire
    Immunome to Present at Upcoming Investor Conferences
    From Immunome, Inc.
    Via Business Wire
    Immunome Reports First Quarter 2025 Financial Results and Provides Business Update
    From Immunome, Inc.
    Via Business Wire
    Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Immunome, Inc.
    Via Business Wire
    Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference
    From Immunome, Inc.
    Via Business Wire
    Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Immunome, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Immunome Reports Full Year 2024 Financial Results and Provides Business Update
    From Immunome, Inc.
    Via Business Wire
    Immunome Doses First Patient in Phase 1 Trial of IM-1021, a ROR1-Targeted ADC
    From Immunome, Inc.
    Via Business Wire
    Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Immunome, Inc.
    Via Business Wire
    Immunome to Present at Upcoming March Conferences
    From Immunome, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Immunome, Inc. - Common Stock publicly traded?
    Yes, Immunome, Inc. - Common Stock is publicly traded.
    What exchange does Immunome, Inc. - Common Stock trade on?
    Immunome, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Immunome, Inc. - Common Stock?
    The ticker symbol for Immunome, Inc. - Common Stock is IMNM on the Nasdaq Stock Market
    What is the current price of Immunome, Inc. - Common Stock?
    The current price of Immunome, Inc. - Common Stock is 10.15
    When was Immunome, Inc. - Common Stock last traded?
    The last trade of Immunome, Inc. - Common Stock was at 09/25/25 04:00 PM ET
    What is the market capitalization of Immunome, Inc. - Common Stock?
    The market capitalization of Immunome, Inc. - Common Stock is 883.61M
    How many shares of Immunome, Inc. - Common Stock are outstanding?
    Immunome, Inc. - Common Stock has 884M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.